The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex

Results of a patient and caregiver survey

Anne M. Skalicky, Anne M. Rentz, Zhimei Liu, James Wheless, Corey L. Pelletier, David W. Dunn, Michael D. Frost, Joanne Nakagawa, Matthew Magestro, Judith Prestifilippo, Chris Pashos

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tuberous sclerosis complex is a genetic disorder characterized by benign tumor growth including lesions in the ventricular system of the brain known as subependymal giant cell astrocytomas. This analysis focuses on the clinical presentation, management, and associated burden of subependymal giant cell astrocytomas in patients with tuberous sclerosis complex in the United States. An institutional review board-approved web-based survey of tuberous sclerosis complex patients and caregivers collected information, and descriptive analyses were conducted on age-based subgroups. A total of 116 tuberous sclerosis complex-subependymal giant cell astrocytoma patients or caregivers responded (17% of the total tuberous sclerosis complex sample). Mean and median patient ages were 25.5 and 23.5 years. Besides subependymal giant cell astrocytomas, patients also experienced skin lesions (72%), seizures (65%), and cognitive concerns (60%). Forty-five percent reported having brain surgery (22% for subependymal giant cell astrocytoma). In the past year, 42% of patients were admitted at least once to the hospital whereas 39% went to the emergency department. Results demonstrate that tuberous sclerosis complex-subependymal giant cell astrocytoma is associated with significant clinical burden, resource utilization, and decreased well-being.

Original languageEnglish (US)
Pages (from-to)563-569
Number of pages7
JournalJournal of Child Neurology
Volume30
Issue number5
DOIs
StatePublished - Apr 27 2015
Externally publishedYes

Fingerprint

Tuberous Sclerosis
Astrocytoma
Caregivers
Inborn Genetic Diseases
Research Ethics Committees
Brain
Surveys and Questionnaires
Hospital Emergency Service
Seizures
Skin
Growth
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex : Results of a patient and caregiver survey. / Skalicky, Anne M.; Rentz, Anne M.; Liu, Zhimei; Wheless, James; Pelletier, Corey L.; Dunn, David W.; Frost, Michael D.; Nakagawa, Joanne; Magestro, Matthew; Prestifilippo, Judith; Pashos, Chris.

In: Journal of Child Neurology, Vol. 30, No. 5, 27.04.2015, p. 563-569.

Research output: Contribution to journalArticle

Skalicky, AM, Rentz, AM, Liu, Z, Wheless, J, Pelletier, CL, Dunn, DW, Frost, MD, Nakagawa, J, Magestro, M, Prestifilippo, J & Pashos, C 2015, 'The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: Results of a patient and caregiver survey', Journal of Child Neurology, vol. 30, no. 5, pp. 563-569. https://doi.org/10.1177/0883073814523318
Skalicky, Anne M. ; Rentz, Anne M. ; Liu, Zhimei ; Wheless, James ; Pelletier, Corey L. ; Dunn, David W. ; Frost, Michael D. ; Nakagawa, Joanne ; Magestro, Matthew ; Prestifilippo, Judith ; Pashos, Chris. / The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex : Results of a patient and caregiver survey. In: Journal of Child Neurology. 2015 ; Vol. 30, No. 5. pp. 563-569.
@article{ba97d606e8634e4aa84909344fd96569,
title = "The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: Results of a patient and caregiver survey",
abstract = "Tuberous sclerosis complex is a genetic disorder characterized by benign tumor growth including lesions in the ventricular system of the brain known as subependymal giant cell astrocytomas. This analysis focuses on the clinical presentation, management, and associated burden of subependymal giant cell astrocytomas in patients with tuberous sclerosis complex in the United States. An institutional review board-approved web-based survey of tuberous sclerosis complex patients and caregivers collected information, and descriptive analyses were conducted on age-based subgroups. A total of 116 tuberous sclerosis complex-subependymal giant cell astrocytoma patients or caregivers responded (17{\%} of the total tuberous sclerosis complex sample). Mean and median patient ages were 25.5 and 23.5 years. Besides subependymal giant cell astrocytomas, patients also experienced skin lesions (72{\%}), seizures (65{\%}), and cognitive concerns (60{\%}). Forty-five percent reported having brain surgery (22{\%} for subependymal giant cell astrocytoma). In the past year, 42{\%} of patients were admitted at least once to the hospital whereas 39{\%} went to the emergency department. Results demonstrate that tuberous sclerosis complex-subependymal giant cell astrocytoma is associated with significant clinical burden, resource utilization, and decreased well-being.",
author = "Skalicky, {Anne M.} and Rentz, {Anne M.} and Zhimei Liu and James Wheless and Pelletier, {Corey L.} and Dunn, {David W.} and Frost, {Michael D.} and Joanne Nakagawa and Matthew Magestro and Judith Prestifilippo and Chris Pashos",
year = "2015",
month = "4",
day = "27",
doi = "10.1177/0883073814523318",
language = "English (US)",
volume = "30",
pages = "563--569",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex

T2 - Results of a patient and caregiver survey

AU - Skalicky, Anne M.

AU - Rentz, Anne M.

AU - Liu, Zhimei

AU - Wheless, James

AU - Pelletier, Corey L.

AU - Dunn, David W.

AU - Frost, Michael D.

AU - Nakagawa, Joanne

AU - Magestro, Matthew

AU - Prestifilippo, Judith

AU - Pashos, Chris

PY - 2015/4/27

Y1 - 2015/4/27

N2 - Tuberous sclerosis complex is a genetic disorder characterized by benign tumor growth including lesions in the ventricular system of the brain known as subependymal giant cell astrocytomas. This analysis focuses on the clinical presentation, management, and associated burden of subependymal giant cell astrocytomas in patients with tuberous sclerosis complex in the United States. An institutional review board-approved web-based survey of tuberous sclerosis complex patients and caregivers collected information, and descriptive analyses were conducted on age-based subgroups. A total of 116 tuberous sclerosis complex-subependymal giant cell astrocytoma patients or caregivers responded (17% of the total tuberous sclerosis complex sample). Mean and median patient ages were 25.5 and 23.5 years. Besides subependymal giant cell astrocytomas, patients also experienced skin lesions (72%), seizures (65%), and cognitive concerns (60%). Forty-five percent reported having brain surgery (22% for subependymal giant cell astrocytoma). In the past year, 42% of patients were admitted at least once to the hospital whereas 39% went to the emergency department. Results demonstrate that tuberous sclerosis complex-subependymal giant cell astrocytoma is associated with significant clinical burden, resource utilization, and decreased well-being.

AB - Tuberous sclerosis complex is a genetic disorder characterized by benign tumor growth including lesions in the ventricular system of the brain known as subependymal giant cell astrocytomas. This analysis focuses on the clinical presentation, management, and associated burden of subependymal giant cell astrocytomas in patients with tuberous sclerosis complex in the United States. An institutional review board-approved web-based survey of tuberous sclerosis complex patients and caregivers collected information, and descriptive analyses were conducted on age-based subgroups. A total of 116 tuberous sclerosis complex-subependymal giant cell astrocytoma patients or caregivers responded (17% of the total tuberous sclerosis complex sample). Mean and median patient ages were 25.5 and 23.5 years. Besides subependymal giant cell astrocytomas, patients also experienced skin lesions (72%), seizures (65%), and cognitive concerns (60%). Forty-five percent reported having brain surgery (22% for subependymal giant cell astrocytoma). In the past year, 42% of patients were admitted at least once to the hospital whereas 39% went to the emergency department. Results demonstrate that tuberous sclerosis complex-subependymal giant cell astrocytoma is associated with significant clinical burden, resource utilization, and decreased well-being.

UR - http://www.scopus.com/inward/record.url?scp=84925677259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925677259&partnerID=8YFLogxK

U2 - 10.1177/0883073814523318

DO - 10.1177/0883073814523318

M3 - Article

VL - 30

SP - 563

EP - 569

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 5

ER -